Becoming a parent is a profoundly personal and treasured experience for countless individuals and couples. Advanced fertility testing sheds light on the road to parenthood, giving women the knowledge they need to make well-informed choices about their reproductive well-being. In this blog post, we underscore the significance of advanced fertility testing in helping women realize their aspirations of parenthood.
Traditional methods of fertility assessment relied on tracking menstrual cycles and basic observations. However, the introduction of advanced fertility testing has transformed the landscape of reproductive health. Women now have access to a range of innovative tests that provide deeper insights into their fertility.
Advanced fertility testing is a range of tests that can be used to assess a woman’s ovarian reserve, egg quality, and other factors that may be affecting her ability to conceive. These tests can be more in-depth and informative than traditional fertility testing, and they can be especially helpful for women who have been trying to conceive for more than a year or who have experienced recurrent pregnancy loss.
Early Detection: Advanced fertility tests can detect potential issues at an earlier stage, providing more time for interventions or fertility preservation if needed.
Personalized Guidance: Results from these tests enable healthcare providers to tailor fertility treatment plans to an individual’s unique needs, increasing the chances of success.
Reducing Stress: Knowing more about one’s fertility status can reduce the emotional burden associated with fertility challenges, allowing couples to make informed choices.
References
[1] Marcelle I Cedars, Evaluation of Female Fertility—AMH and Ovarian Reserve Testing, The Journal of Clinical Endocrinology & Metabolism, Volume 107, Issue 6, June 2022, Pages 1510–1519, https://doi.org/10.1210/clinem/dgac039
[2] De Rycke M, Berckmoes V. Preimplantation Genetic Testing for Monogenic Disorders. Genes. 2020; 11(8):871. https://doi.org/10.3390/genes11080871
[3] Rezk, Mohamed & Shawky, Mohamed. (2014). The safety and acceptability of saline infusion sonography versus hysterosalpingography for evaluation of tubal patency in infertile women. Middle East Fertility Society Journal. 20. 10.1016/j.mefs.2014.06.003.
[4] Elkhalek, Yasser & Kamel, Omar & El-Sabaa, Haitham. (2016). Comparison of 3 dimensional sonohysterography and hysteroscopy in Premenopausal women with abnormal uterine bleeding. The Egyptian Journal of Radiology and Nuclear Medicine. 47. 10.1016/j.ejrnm.2016.04.020.
SG-NONF-00301
MERCK | Copyright 2024 – All Rights Reserved
SG-FTHE-00020
Endorsed by
Malaysia: Merck Sdn Bhd, B-23A-1, Level 23A, The Ascent Paradigm, No 1, Jalan SS7/26A, Kelana Jaya, 47301 Petaling Jaya, Selangor Darul Ehsan | Singapore: Merck Pte Ltd, 2 Science Park Dr, 05-01/12, Singapore 118222